<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202526/bin/ol-16-05-6552-g04.jpg"/> </div> <div class="text-side"> <h1>HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression.</h1> <p>Effect of apicidin on PCNA, HDAC8, apoptosis and autophagy in AT-84 cell-derivated allografts. (A) H&amp;E staining of tumor sections (magnification, ×200), and immunohistochemistry for PCNA and HDAC8 were performed on paraffin-embedded tumor sections (magnification, ×400). (B) TUNEL assay and immunohistochemistry for LC3B and p62 were performed on paraffin-embedded tumor sections (magnification, ×400). (C) Positive cells of immunostaining and TUNEL were counted, and the results are expressed as the mean ± standard deviation. Five random fields from each experiment were counted under a microscope at maginification, ×400. The index was calulated assuming that the amount of positive cells in the control was 100%. ***P&lt;0.001, compared with the vehicle-treated control group. H&amp;E, hematoxylin and eosin; LC3B, microtubule associated protein 1 light chain 3B; PCNA, proliferating cell nuclear antigen; HDAC8, histone deacetylase 8; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30405794/" target="_blank">30405794</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>